Kaffarnik H, Schneider J, Haase W
Dtsch Med Wochenschr. 1975 Nov 28;100(48):2486-8. doi: 10.1055/s-0028-1106571.
In a clinical trial of 21 patients with hypercholesteraemia and (or) hypertriglyceridaemia, the effects of etofibrate and clofibrate were compared with one another and against a placebo: both drugs lowered triglyceride levels significantly, but etofibrate also had a stronger cholesterol-lowering effect. Both substances were well tolerated.
在一项针对21名高胆固醇血症和(或)高甘油三酯血症患者的临床试验中,比较了益多酯和氯贝丁酯的疗效,并与安慰剂进行了对照:两种药物均能显著降低甘油三酯水平,但益多酯的降胆固醇效果更强。两种药物的耐受性都很好。